Abaxx Technologies Inc. Reports Record Second Quarter 2026 Results

Abaxx Technologies Inc. (TSX:ABXX, OTCQX:ABXXF) reported Q2 2026 results, citing a 276% QoQ rise in total volume to 888,902 contracts and ADV to 14,572. Transaction and clearing fees were C$4.50M. The company reported a net loss of C$28.8M and ended Q2 with C$95.1M cash after raising C$69.0M gross proceeds. It also updated IFRS 15 accounting for liquidity credits.

Original reporting
Published Aug 17, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 12:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ABXXF
Bullish
medium confidence
Mentioned
$ABXXF
Relevance
8/10
AlphAI data visualization · based on montrealgazette.com
Decision brief

The 30-second read

$ABXXFBullishMed
01

Why it matters

The company accelerated exchange participation efforts, expanded distribution to LSEG and Bloomberg, added a mainland China-backed clearing member, and launched new futures products, driving record volumes and higher fees. It also raised $69.0M gross proceeds and reported a larger net loss partly due to derivative mark-to-market and accounting reclassifications.

02

Market read

Traders can reassess Abaxx’s growth rate in exchange volumes and fee generation, and the balance-sheet impact of the $69M equity raise, while monitoring profitability headwinds from non-cash derivative losses and accounting presentation changes.

03

What to watch

Accounting changes reclassify liquidity-related credits and timing of program payments, which can complicate quarter-to-quarter revenue comparisons even if cash is unchanged.

Relevance 8/10Novelty 8/10Timing: reported Q2 2026 results today (Aug. 17, 2026)

Background

Abaxx is a financial software and market infrastructure company and majority shareholder of Abaxx Singapore, owner of Abaxx Commodity Exchange and Clearinghouse.

Company-level read

Ticker impact

$ABXXFBullishMedium confidence
Context

Abaxx reported Q2 2026 results with record volume 888,902 contracts (+276% QoQ) and higher transaction and clearing fees.

Expected impact

Moderately positive bias for the stock, with volatility likely due to net loss and derivative-driven non-cash items.

Evidence & confidence

The article provides concrete operating metrics (volume, ADV, open interest) and fee growth, but also shows net loss widening and accounting reclassifications that can affect reported revenue trends.

Market effects

Highlights momentum in exchange and clearing participation, which can influence sentiment toward financial market infrastructure software and trading venues.

Emphasizes Asia connectivity via a mainland China-backed clearing and trading member, potentially improving regional growth expectations.

LSEG and Bloomberg distribution expansion supports broader global market data reach and recurring revenue potential.

Counterpoint

Reported net loss increased to $28.8M and includes a $6.1M unrealized derivative loss, so fee growth may not translate into near-term profitability.

Key entities

  • Abaxx Technologies Inc.

    Reported record Q2 2026 exchange participation metrics, fee growth, capital raise, and net loss, alongside operational and technology commercialization updates.

  • Yongan International Financial (Singapore) Pte. Ltd.

    Became Abaxx Exchange’s first mainland China-backed clearing and trading member, supporting Asia participation growth.

  • Alta Alternative Investments Pte. Ltd.

    Entered a commercial agreement to advance money market fund shares as yield-bearing T+0 margin collateral at Abaxx Clearing.

  • LSEG and Bloomberg

    Market data and pricing became available on more than 400,000 institutional terminals via licensing and distribution infrastructure.

Related articles

$JNJHighAI 9/10

Johnson & Johnson reports Q3 2026 results, raises 2026 guidance

JOHNSON & JOHNSON (JNJ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Media contact: media-relations@its.jnj.com Investor contact: investor-relations@its.jnj.com For immediate release Johnson & Johnson reports Q3 2026 results, raises 2026 guidance • 2026 Third-Quarter reported sales growth of 5.9% to $25.4 Billion with operational grow

$MIRMMedAI 8/10

Announcement of Data from the Phase 3 EXPAND Study of LIVMARLI (maralixibat) in Ultra-Rare Cholestatic Liver Diseases On October 12, 2026, Mirum…

Mirum Pharmaceuticals, Inc. (MIRM) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. Announcement of Data from the Phase 3 EXPAND Study of LIVMARLI (maralixibat) in Ultra-Rare Cholestatic Liver Diseases On October 12, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) announced topline results from the Phase 3 EXPAND study evaluating LIVMAR

$GSHighAI 8/10

Goldman Sachs beats third quarter estimates on trading strength

Goldman Sachs (GS) reported Q3 earnings of $17.01 per share, beating estimates by $3.92. Revenue rose 23% YoY to $18.68B, driven by strong trading and investment banking. Shares gained 2.9% premarket. Global Banking & Markets revenue increased 32% YoY to $13.46B. Investment banking fees rose 21% to $3.22B, while equities revenue surged 72% to $6.44B. Operating expenses increased 20% to $11.31B. The board declared a $5.00 quarterly dividend.